These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 5872971)

  • 41. Experience in the preparation and experimental use of immunocytostatics.
    Embleton MJ; Pimm MV; Garnett MC; Rowland GF; Simmonds RG; Baldwin RW
    Behring Inst Mitt; 1984 May; (74):108-12. PubMed ID: 6591915
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Adenoviral thymidine kinase prodrug gene therapy inhibits sarcoma growth in vivo.
    Ross HM; Hirschowitz EA; Russi TJ; Crystal RG; Nawata S; Burt ME; Brennan MF; Lewis JJ
    J Surg Res; 1997 Jun; 70(1):7-11. PubMed ID: 9228920
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Experimental significance of anti-sarcoma "PT" antibodies in antineoplastic immunology in the mouse].
    Ferrari S; Lucchesi M; Serafini NA
    Ann Ist Carlo Forlanini; 1966; 26(4):469-79. PubMed ID: 5991599
    [No Abstract]   [Full Text] [Related]  

  • 44. [Effects of Proteus mirabilis on tumor growth of rats].
    Bay ML; Comba JO; Amerio N; Morini JC
    Medicina (B Aires); 1982; 42(5):507-12. PubMed ID: 6763128
    [No Abstract]   [Full Text] [Related]  

  • 45. [Effect of stable regional vascular hypotension on malignant tumor growth].
    Rudenko FV
    Kosm Biol Aviakosm Med; 1981; 15(3):65-7. PubMed ID: 7289547
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inhibitory effects of a new bisphosphonate, minodronate, on proliferation and invasion of a variety of malignant bone tumor cells.
    Kubo T; Shimose S; Matsuo T; Tanaka K; Yasunaga Y; Sakai A; Ochi M
    J Orthop Res; 2006 Jun; 24(6):1138-44. PubMed ID: 16705696
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The effect of blockage of macrophage on tumor-suppressive activity of polyactin B.
    Xu C; Wang X; Wang B; Han S; Zhang Y; Si L
    Chin Med J (Engl); 1998 Sep; 111(9):861-3. PubMed ID: 11155684
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Anticancer activity of rViscumin (recombinant mistletoe lectin) in tumor colonization models with immunocompetent mice.
    Schaffrath B; Mengs U; Schwarz T; Hilgers RD; Beuth J; Möckel B; Lentzen H; Gerstmayer B
    Anticancer Res; 2001; 21(6A):3981-7. PubMed ID: 11911280
    [TBL] [Abstract][Full Text] [Related]  

  • 49. 2-substituted piperazines as constrained amino acids. Application to the synthesis of potent, non carboxylic acid inhibitors of farnesyltransferase.
    Williams TM; Ciccarone TM; MacTough SC; Bock RL; Conner MW; Davide JP; Hamilton K; Koblan KS; Kohl NE; Kral AM; Mosser SD; Omer CA; Pompliano DL; Rands E; Schaber MD; Shah D; Wilson FR; Gibbs JB; Graham SL; Hartman GD; Oliff AI; Smith RL
    J Med Chem; 1996 Mar; 39(7):1345-8. PubMed ID: 8691462
    [No Abstract]   [Full Text] [Related]  

  • 50. Effects of different shortwave radiofrequencies on tumor growth.
    Auda SP; Vuthiganon C; Elias EG
    Cancer Res; 1980 Aug; 40(8 Pt 1):2829-34. PubMed ID: 7388833
    [No Abstract]   [Full Text] [Related]  

  • 51. Chromosomal changes in the Jensen tumor by tumor polypassage.
    Nachtigal M; Popescu N; Nachtigal S
    Arch Immunol Ther Exp (Warsz); 1967; 15(5):812-7. PubMed ID: 5595084
    [No Abstract]   [Full Text] [Related]  

  • 52. Experimental tumour immunology.
    Nagy I; Ats M; Koszoru M; Majorossy K
    Arch Ital Patol Clin Tumori; 1966; 9(1):81-7. PubMed ID: 5998090
    [No Abstract]   [Full Text] [Related]  

  • 53. In vivo antitumor activity of TT-232 a novel somatostatin analog.
    Tejeda M; Gaal D; Schwab RE; Pap A; Keri G
    Anticancer Res; 1999; 19(4B):3265-8. PubMed ID: 10652622
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Wortmannin, a phosphoinositide 3-kinase inhibitor, selectively enhances cytotoxicity of receptor-directed-toxin chimeras in vitro and in vivo.
    Davol PA; Bizuneh A; Frackelton AR
    Anticancer Res; 1999; 19(3A):1705-13. PubMed ID: 10470104
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Experimental use of antitumor preparations in low doses].
    Garkavi LKh; Kvakina EB; Mulatova AK; Taras'iants FM
    Vopr Onkol; 1981; 27(7):61-6. PubMed ID: 6791380
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of intratumoral injection of carboplatin combined with pluronic P85 or L61 on experimental colorectal carcinoma in rats.
    Krupka TM; Weinberg BD; Wu H; Ziats NP; Exner AA
    Exp Biol Med (Maywood); 2007 Jul; 232(7):950-7. PubMed ID: 17609512
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Study of the biochemical mechanism of the action of new antineoplastic compounds].
    Shukurian SG; Chil-Akopian LA; Demirchoglian IG
    Zh Eksp Klin Med; 1970; 10(2):41-6. PubMed ID: 5450094
    [No Abstract]   [Full Text] [Related]  

  • 58. Kinetics of the acute-phase reaction in rats after tumor transplantation.
    Abd-el-Fattah M; Scherer R; Fouad FM; Ruhenstroth-Bauer G
    Cancer Res; 1981 Jun; 41(6):2548-55. PubMed ID: 6972253
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Studies in mice treated with ICRF-159 combined with daunorubicin or doxorubicin.
    Giuliani F; Casazza AM; Di Marco A; Savi G
    Cancer Treat Rep; 1981; 65(3-4):267-76. PubMed ID: 6263470
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Changes in the virulence and immunogenicity of malignant cells under the effect of K-4 preparation].
    Montsevichiute-Eringene
    Patol Fiziol Eksp Ter; 1966; 10(3):58-9. PubMed ID: 5239877
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.